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Methods: 
Materials and Reagents 
All chemicals were used as received from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. Tetrahydrofuran (THF) was collected from a dry solvent system 
and used immediately thereafter. Benzyl alcohol was dried over calcium hydride 
and distilled before titration with potassium naphthalenide in THF (0.3 M). Ethylene 
oxide (EO) was degassed through several freeze-pump-thaw cycles and distilled to a 
flame-dried buret immediately before use. Potassium naphthalenide was prepared 
from potassium metal and recrystallized naphthalene in dry THF and allowed to stir 
with a glass-coated stir-bar for 24 hours at room temperature before use. Ethylene 
glycol vinyl glycidyl ether (EGVGE) was synthesized by reacting ethylene glycol 
vinyl ether with epichlorohydrin in basic conditions, distilled to a buret and 
degassed in vacuo before use. Allyl glycidyl ether (AGE) was purchased from TCI-
America (Portland, OR), degassed through several freeze-pump-thaw cycles, and 
distilled from butyl magnesium chloride to a buret for storage. (Bim)3 and 
(BimC4A)3 were provided by Prof. M.G. Finn at the Georgia Institute of Technology. 
All DNA oligos (Table S1) were synthesized, modified and purified by Integrated 
DNA Technologies (Coralville, IA). Nucleolin was purchased from Abcam 
(Cambridge, MA). Human α-thrombin was purchased from Haematologic 
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Technologies (Essex Junction, VT). Immunoglobulin E (IgE) was purchased from 
Athens Research and Technology (Athens, GA). Gelstar and MEGM (Mammary 
Epithelial Cell Growth Medium) BulletKit were purchased from Lonza (Allendale, 
NJ). M-270 carboxylic acid-coated magnetic bead and LIVE/DEAD 
Viability/Cytotoxicity Kit for mammalian cells were purchased from Life 
Technologies (Carlsbad, CA). iQ SYBR Green Supermix was purchased from Bio-Rad 
Laboratories (Hercules, CA) for quantitative PCR experiments. Dulbecco’s 
Phosphate Buffered Saline solution (DPBS, calcium and magnesium-free), agarose 
and 10× PBS were purchased from Thermo Fisher Scientific (Waltham, MA). 
Dulbecco’s Modified Eagle’s Medium (DMEM) was purchased from American Type 
Culture Collection (ATCC, Manassas, VA). Fetal bovine serum (FBS) and penicillin-
streptomycin were used as received from Life Technologies (Carlsbad, CA).  
 
Synthesis of poly(EGVGE)-b-(EO) (1) 
All polymerizations were carried out on a Schlenk line in custom thick-walled glass 
reactors fitted with ACE-threads under an argon atmosphere. The reactors were 
dried under vacuum then refilled with argon five times. Under an argon atmosphere, 
benzyl alcohol initiator was added by gas-tight syringe through a 6-mm Puresep 
(Herefordshire, UK) septum. THF was then added by opening the valve of the 
already-connected buret on the reactor. The potassium alkoxide initiator was 
formed by titration of benzyl alcohol with potassium naphthalenide under argon 
until a green color persisted in solution, indicating the deprotonation of all alcohols. 
EGVGE was first added into the reactor, and polymerization was carried out at 45 °C 
for 20 hrs. EO was then added and the reactor was maintained at 45 °C for an 
additional 48 h until the polymerization was terminated with isopropanol. Polymers 
were precipitated in hexane and dried in vacuo before characterization (yield > 
95%). 1H NMR of Poly(EGVGE)-b-(EO) (1) (500 MHz, CDCl3): δ 3.54–3.71 (broad m, 
–CH2–CH–O–CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 3.81/3.82 (two broad 
peaks, –CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 4.00/4.19 (doublet of doublets, 
–O–CH=CH2), 4.51–4.55 ppm (four singlets, Ph–CH2–O–), 6.49 (m, –O–CH=CH2), 7.32 
(overlap with residual CHCl3, 1H on Ph–CH2–O–), 7.38 (s, 4H on Ph–CH2–O–). 13C 
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NMR of Poly(EGVGE)-b-(EO) (500MHz, CDCl3): δ 61.6 (s, –CH2–OH of chain ends), 
67.4 (s, –CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 69.8–72.6 (broad m, –CH2–
CH2–O–CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 73,4 (s, Ph–CH2–O–), 77.2 
(triplet, CDCl3), 78.6 (s, –O–CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 86.7 (s, –O–
CH=CH2), 127.6/128.4 (doublet, 5C on Ph–CH2–O–), 151.8 (s, –O–CH=CH2). See 
Figure S14 and Figure S15A for characterization data. 
 
 
 
Alkyne functionalization of poly(EGVGE)-b-(EO) (2) 
Poly(EGVGE)-b-(EO) (1) (1.0 g, 0.087 mmol) was placed in a 50 mL round-bottom 
flask sitting on an ice bath. 10 ml of dry toluene was added and the mixture was 
stirred with a magnetic stir-bar until the polymer was fully dissolved in the solvent. 
Crushed potassium hydroxide (48 mg, 0.87 mmol) was then slowly added to the 
mixture at 0 °C to avoid generating excess heat. After 2 hours, propargyl bromide 
(260 mg, 1.7 mmol) was added dropwise and the reaction flask was moved to a 
50 °C oil bath and stirred for an additional 48 hours. After cooling the reaction 
mixture, the potassium bromide precipitate was filtered and the solvent was 
evaporated. The polymer was then washed several times with water and 
precipitated in hexane. 1H NMR of the alkyne-functionalized Poly(EGVGE)-b-(EO) (2) 
(500 MHz, CDCl3): δ 2.44 (singlet, –O–CH2–C=CH) 3.54–3.71 (broad m, –CH2–CH–O–
CH2–CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 3.81/3.82 (two broad peaks, –CH2–
CH(CH2–O–CH2–CH2–O–CH=CH2)–O–), 4.00/4.19 (doublet of doublets, –O–CH=CH2), 
4.21/4.22 (doublet, –O–CH2–C=CH), 4.51–4.55 ppm (four singlets, Ph–CH2–O–), 6.49 
(m, –O–CH=CH2), 7.32 (overlap with residual CHCl3, 1H on Ph–CH2–O–), 7.38 (s, 4H 
on Ph–CH2–O–). See Figure S15B for characterization data. 
 
Alkyne functionalized, hydroxyl-grafted poly(EGGE)-b-(EO) (3) 
Alkyne-functionalized poly(EGVGE)-b-(EO) (2) (1.0 g, 0.087 mmol) was placed in a 
50 mL round-bottom flask. 10 ml of methanol was added and the mixture was 
stirred with a magnetic stir-bar. Para-toluene sulfonic acid (34 mg, 0.087 mmol) was 
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added and the reaction was stirred at room temperature for 3 hours. The resulting 
polymer was washed several times with water and precipitated in hexane (yield > 
95%). 1H NMR of the alkyne functionalized poly(EGGE)-b-(EO) with deprotected 
alcohols along the backbone (3) (500 MHz, CDCl3): δ 2.44 (singlet, –O–CH2–C=CH) 
3.54–3.71 (broad m, –CH2–CH–O–CH2–CH(CH2–O–CH2–CH2–OH)–O–), 4.21/4.22 
(doublet, –O–CH2–C=CH), 4.51–4.55 ppm (four singlets, Ph–CH2–O–), 7.32 (overlap 
with residual CHCl3, 1H on Ph–CH2–O–), 7.38 (s, 4H on Ph–CH2–O–). See Figure 
S15C for characterization data. 
 
Synthesis of the Polymer Scaffold with Cleavable Coumarin Payload (4) 
Alkyne-functionalized, vinyl-deprotected poly(EGGE)-b-(EO) (3) (100 mg, 0.090 
mmols alcohol) and carboxylic acid-functionalized coumarin [7-(diethylamino)-2-
oxo-2H-chromene-3-carboxylic acid]1 (36 mg, 0.14 mmols) were dissolved in 5 mL 
dry methylene chloride. A solution of N,N’-dicyclohexylcarbodiimide (29 mg, 0.14 
mmols) in 2 mL dry methylene chloride was added dropwise at 0 °C. The solution 
was allowed to warm to room temperature and stirred for 24 hours. The solution 
was then concentrated to ~ 2 mL and precipitated into hexanes. The precipitate was 
collected and further purified by preparatory gel-permeation chromatography (GPC) 
to yield the desired material as a fluorescent powder (40 mg). (yield ~ 88%) See 
NMR and GPC data in Figure S15D and Figure S16, respectively.  
 
Synthesis of the Polymer Scaffold with Cleavable Doxorubicin Units (7)  
First, 1.0 g (0.091 mmol) of alkyne-functionalized poly(EGGE)-b-(EO) (3) was mixed 
with succinic anhydride (450 mg, 4.5 mmol) and 4-dimethylaminopyridine (110 mg, 
0.91 mmol) in a 100 mL round-bottom flask. The mixture was dried in vacuo 
overnight before 10 mL of dichloromethane was added. The heterogeneous solution 
was stirred at 20 °C for 8 hrs before being filtered. The functionalized polymer (6) 
was then precipitated out of ethyl ether.  
 
Second, the doxorubicin-conjugated polymer was synthesized by a slight 
modification to the procedure of Yoo et al.,2 because the grafted carboxylic acid 
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groups react more with primary alcohols on doxorubicin rather than the secondary 
ones. Specifically, 9-fluorenylmethyl chloroformate (Fmoc)-protected doxorubicin 
(16 mg, 0.022 mmols) and a carboxylic acid-containing copolymer (6) were added 
to 1 mL dry methylene chloride. Dicyclohexyl carbodiimide (6 mg, 0.029 mmol) and 
a catalytic amount of 4-dimethylaminopyridine (1 mg) were dissolved in a separate 
aliquot of 1 mL dry dichloromethane and added dropwise to the Fmoc-Dox/polymer 
solution. The reaction was allowed to stir 24 hours, after which time the reaction 
mixture was quenched by addition of 10 mL 1 N HCl and extracted 3× with 
chloroform. The organic layers were combined, the solvent was removed and the 
product mixture purified by preparatory GPC using chloroform with 0.25 mole % 
triethylamine as the eluent to yield a red powder. The product was redissolved in 
N,N-dimethylformamide and 250 μL piperidine was added, yielding a deep purple 
solution. The reaction mixture was allowed to stir for 10 minutes, the solvent was 
removed under vacuum, and the product was redissolved in chloroform and 
purified by preparatory GPC using chloroform with 0.25 mole % triethylamine as 
the eluent to yield a red powder as the final product. See NMR data in Figure S17.  
 
Synthesis of poly[(allyl glycidyl ether)-co-(ethylene oxide)] (8) 
All polymerizations were carried out on a Schlenk line in custom thick-walled glass 
reactors fitted with ACE-threads under an argon atmosphere. The reactors were 
dried under vacuum then refilled with argon five times. Under an argon atmosphere, 
benzyl alcohol initiator was added by gas-tight syringe through a 6-mm Puresep 
(Herefordshire, UK) septum. THF was then added by opening the valve of the 
already-connected buret on the reactor. The potassium alkoxide initiator was 
formed by titration of benzyl alcohol with potassium naphthalenide under argon 
until a green color persisted in solution, indicating the deprotonation of all alcohols. 
Allyl glycidyl ether (AGE) and EO were simultaneously added into the reactor, and 
polymerization was carried out at 45 °C for 20 hrs until the polymerization was 
terminated with isopropanol. Then the resulting copolymers were precipitated in 
hexane and dried in vacuo before characterization (yield > 95%). 1H NMR of 
 S6 
 
Poly(EO-co-AGE)  (500 MHz, CDCl3): δ 1.55 (d, –O–CH=CH–CH3), 3.47–3.72 (broad m, 
–CH2–CH–O–CH2–CH(CH2–O–CH2–CH=CH2)–O– and –CH2–CH–O–CH2–CH(CH2–O–
CH=CH–CH3)–O–), 3.79/3.87 (two broad peaks, –CH2–CH(CH2–O–CH=CH–CH3)–O–), 
4.01 (d, –O–CH2–CH=CH2), 4.38 (m, –O–CH=CH–CH3), 4.53–4.56 (four singlets, Ph-
CH2–O–), 5.18/5.28 (doublet of doublets, –O–CH2–CH=CH2), 5.91 (m, –O–CH2–
CH=CH2), 5.97 (d, –O–CH=CH–CH3), 7.30 (overlap with residual CHCl3, 1H on Ph–
CH2–O–), 7.36 (s, 4H on Ph–CH2–O–).13C NMR of Poly(EO-co-AGE) (500 MHz): δ 70.9 
(–CH2–CH2–O–CH2–CH(CH2–O–CH2–CH=CH2)–O–), 72.0 (–O–CH2–CH=CH2), 79.4 (–
CH2–CH(CH2–O–CH2–CH=CH2)–O–), 100.3 (–O–CH=CH–CH3), 116.3 (–O–CH2–
CH(CH2–O–CH2–CH=CH2)–O–), 127.5/128.6 (5C, Ph–CH2–O–), 135.6 (–CH2–CH(CH2–
O–CH2–CH=CH2)–O–), 138.8 (1C, Ph–CH2–O–), 146.8 (–CH2–CH(CH2–O–CH=CH–
CH3)–O–). 
 
Synthesis of the Polymer Scaffold with Non-cleavable Coumarin Payload (10) 
Poly(allyl glycidyl ether)6-b-(ethylene oxide)120 (PAGE6-b-PEO120) (8) (2.2g, 0.37 
mmol) and m-chloroperbenzoic acid (0.65g, 5.5 mmol) were dissolved in methylene 
chloride (Scheme S2). The solution was then stirred overnight at room temperature 
and the product (9) was purified by precipitation in diethyl ether. The resulting 
polymer has approximately three epoxides and three allyl group grafted along the 
backbone. The epoxidized polymer was then reacted with three equivalents of an 
amine functional coumarin dye (N-(2-aminoethyl)-7-(diethylamino)-2-oxo-2H-
chromene-3-carboxamide)3 in dry THF at room temperature for 36 hours to yield a 
material with grafted coumarin units. (yield ~ 52%) See NMR data in Figure S18.  
 
Characterization of Polymer Scaffold 
1H NMR spectroscopy was carried out on a Bruker (Billerica, MA) AC 500 
spectrometer in deuterated chloroform (CDCl3). Size exclusion chromatography 
(SEC) was performed on a Waters (Milford, MA) chromatograph with four Viscotek 
(Malvern, Worcestershire, UK) columns (two I-MBHMW-3078, I-series mixed-bed, 
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high-molecular-weight columns and two I-MBLMW-3078, I-series mixed-bed, low-
molecular-weight columns) for fractionation, a Waters 2414 differential 
refractometer and 2996 photodiode array detector for detection of eluent, with 
chloroform with 0.1% triethylamine at room temperature used as the mobile phase. 
Gas chromatography was carried out on a Shimadzu (Kyoto, Japan) GC-2014 using a 
flame ionization detector and a Restek (Bellefonte, PA) column (SHRXI-5MS) for 
separation. DSC measurements were performed using a TA Instruments Q2000 
modulated differential scanning calorimeter with 50-position auto-sampler and 
mass flow control in the temperature range from −80 to 120°C at a heating rate of 
10 K/min and cooling rate of −5 K/min under nitrogen. 
 
Ligand-Accelerated CuAAC Conjugation 
2 µL of 50 mM Cu(II) salt (CuSO4) in water and 2 µL of 100 mM ligand ((Bim)3 or 
(BimC4A)3) in 3:1 dimethyl sulfoxide:tert-butanol (DMSO/t-BuOH) were mixed, 
after which 2 µL of 0.5 mM azide-modified DNA oligos in water, 1.25 mM polymer 
with an alkyne end group in DMSO/t-BuOH and 2 µL of 10× PBS were added to the 
mixture. 4 µL of a freshly prepared sodium ascorbate solution in water (200 mM) 
was subsequently added and completely mixed. The solution was shaken at room 
temperature overnight and used for gel electrophoresis or RT-PCR without further 
purification. For affinity measurements and confocal microscopy experiments, the 
reaction was diluted with 500 µL of water, and the conjugate was filtered and 
purified three times using Amicon Ultra (Millipore, Billerica, MA) centrifugal filters. 
The purified conjugate was quantified via UV-vis measurement at 260 nm.  
 
Gel Electrophoresis 
All CuAAC reaction products were analyzed via electrophoresis on a 2% agarose gel 
with 1× Gelstar staining dye in 1× TBE buffer (89 mM Tris borate, 2 mM Na2EDTA, 
pH 8.3) at 150 V for 40 mins. Each sample contained 0.25 μL of CuAAC reaction 
product and 5 μL of 15% glycerol. In parallel, we ran 1.5 μL of low molecular weight 
DNA ladder (20 base) and 5 μL of 15% glycerol, and 0.25 μL each of 50 μM 
unconjugated aptamer and 500 μM unconjugated polymer mixed with 5 μL of 15% 
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glycerol as negative controls. Gel images were taken with a Kodak Gel Logic 200 
imaging system equipped with Kodak molecular imaging software (Carestream 
Health, Rochester, NY). 
 
Quantitative PCR Experiments 
CuAAC conjugate were also quantified by PCR. PCR reactions contained 10 µL iQ 
SYBR Green Supermix, 8.8 µL PCR water, 0.1 µL of 0.1 mM forward primer, 0.1 µL of 
0.1 mM reverse primer and 1 µL of diluted CuAAC product or an equal concentration 
of unconjugated aptamer, with fluorescence signal monitored using the iQ 5 multi-
color real time-PCR Detection System (Bio-Rad Laboratories). CT (threshold cycle) 
values were subsequently determined for each sample. 
 
Affinity Measurements 
Each sample’s Kd was measured via a fluorescence-based binding assay4. CuAAC 
reaction products or mixtures of unconjugated aptamer and polymer scaffold in 1: 
10 ratio were diluted to several different concentrations (from 0 to 100 nM, 50 nM 
and 25 nM for nucleolin, thrombin and IgE, respectively) in 90 µL of binding buffer. 
This buffer consisted of 1× PBS, pH 7.4 containing 1 mM MgCl2 and 0.025% 
Tween20 (v/v) for nucleolin and IgE, and 100 mM Tris, 20 mM MgCl2, 150 mM NaCl, 
pH 7.4 and 0.025% Tween20 (v/v) for thrombin. These dilutions were heated at 
95 °C for 10 min, immediately cooled on ice for 10 min and then incubated for 
another 10 min at room temperature. We measured the Kd by incubating these heat-
treated samples with target protein-coated M-270 magnetic beads (2×109 beads/mL, 
2.8 µm in diameter) in a total volume of 100 µL for 1 hour at room temperature. 1 
µL of nucleolin (2.34×105 molecules/bead), 2.5 µL of thrombin (1.05×105 
molecules/bead) or 2.5 µL of IgE (5.97×104 molecules/bead) were immobilized 
onto the beads through the EDC-NHS coupling process using the manufacturer’s 
protocol, and quantified with the NanoOrange Protein Quantitation Kit (Life 
Technologies). After incubating with our samples, the magnetic beads were 
thoroughly washed three times with binding buffer, and magnetic separation was 
used to eliminate unbound molecules. Bound molecules were released into 55 µL of 
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water or DMSO by heating the beads at 95 °C for 10 min. 50 µL of each eluate was 
transferred to a black 96-well microplate (Microfluor 2, Thermo Scientific), and 
released molecules were quantified by fluorescence measurement using a 
microplate reader (Tecan, San Jose, CA). Eluates in water and DMSO were used for 
fluorescence measurements of Cy5-labeled aptamer and coumarin-linked polymer 
scaffold, respectively. We calculated Kd from the calibrated curve fitting using the 
equation Y = Bmax × X/ (Kd + X), where X is the concentration of ssDNA and Bmax is 
the fluorescence value at saturation. 
 
Kinetic Fluorescence Measurement of Coumarin Release 
To monitor kinetics of enzyme-dependent coumarin release, coumarin-loaded 
nucleolin APHs (5) were dissolved in 1× PBS, pH 7.4, and PLE (150 units/mL) was 
then added to produce a solution containing 500 nM conjugate and 1.5 U PLE in 100 
µL. As a control, we prepared 100 µL of 10 µM free coumarin in 1× PBS, pH 7.4 
containing 1.5 U PLE in 100 µL. At a set time, fluorescence spectra of these samples 
were immediately recorded in a black 96-well microplate with a Tecan Infinite 
M1000 microplate reader. The excitation wavelength was set at 410 nm and 
emission was recorded from 420–700 nm with excitation and emission slits of 5 nm. 
Time-dependent changes in fluorescence intensity at 470 nm were also measured 
every minute over 3 hours with different amounts of PLE, from 0 to 1.5 U. 
 
Cell Culture and Sample Preparation 
MCF-7 cells were cultured as recommended by the ATCC in DMEM supplemented 
with 10% FBS and 1% penicillin/streptomycin. MCF10A cells were cultured in 
MEGM complete growth medium as recommended by the ATCC. All cell cultures 
were grown in a humidified incubator maintained at 37 °C and 5% CO2. For live-cell 
imaging, cells were harvested with a 0.25% Trypsin, 0.53 mM EDTA solution and 
seeded on 35-mm glass bottom dishes 24 hours before the experiment. The medium 
was then removed, and the cells were washed twice with pre-warmed DPBS. The 
washed cells were incubated with 500 nM solutions of each sample for 5 mins, 
thoroughly washed with pre-warmed DPBS twice, and then incubated with fresh 
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medium at 37 °C for 4 hours. At a set time, all samples were immediately observed 
via confocal microscopy. 
 
Confocal Microscopy Measurement 
Confocal microscopy measurements were performed with an Olympus (Tokyo, 
Japan) FluoView 500, mounted on an Olympus IX81 inverted microscope with a 40× 
oil immersion objective. 405-nm diode laser and 633-nm HeNe laser lines were used 
to excite coumarin (emission filter 465–495 nm) and Cy5 (emission filter >630 nm), 
respectively. All images were analyzed using ImageJ software. Cells were grown on 
MatTek plates (Ashland, MA). During kinetic experiments, all cells were kept at 
37 °C and 5% CO2. 
 
APH-Mediated DOX Delivery 
In order to completely remove unreacted DOX-loaded polymers after the CuAAC 
reaction, APHs were purified using complementary DNA-coated, M-270 magnetic 
beads. Specifically, the reaction sample was diluted 10× with binding buffer and 
incubated with magnetic beads for 10 min at RT. The magnetic beads were washed 
twice with binding buffer, and bound APHs were then released into water by 
heating at 95 °C for 10 min. APH concentration was determined by UV-vis and Cy5 
fluorescence measurements. MCF-7 cells (1 × 105 cells/mL) were grown in 96-well 
plates for 48 hrs and thoroughly washed twice with pre-warmed DPBS. Washed 
MCF-7 cells were treated with 500 nM unconjugated nucleolin aptamer, 
unconjugated polymer with DOX or DOX-loaded nucleolin APH in DMEM and 
incubated at 37 °C for four days. All experiments were performed in triplicate. Cell 
viability was measured via LIVE/DEAD Viability/Cytotoxicity Kit (Life Technologies), 
in which viable cells and nonviable cells were stained by calcein acetoxymethyl 
ester (green) and ethidium homodimer-1 (red), respectively. Staining was 
performed according to the manufacturer’s protocol, and cell viability was 
subsequently analyzed using a microplate reader (Tecan).  
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Table S1: DNA Sequences used in the experiments 
 
Name Sequence Description 
NCL-
Apt1 
5’-GGAAGAGATGGCGACGGTGGT 
GGTGGTTGTGGTGGTGGTGGAGCTGAT
CCTGATGG-Azide-3’ 
Nucleolin aptamer sequence 
flanked by primer binding sites 
(azide tag at 3’ terminus) 
Th-
Apt1 
5’-GGAAGAGATGGCGAC 
GGTTGGTGTGGTTGG 
AGCTGATCCTGATGG-Azide-3’ 
Thrombin aptamer sequence 
flanked by primer binding sites 
(azide tag at 3’ terminus) 
IgE-
Apt1 
5’-GGAAGAGATGGCGACCACGTTT 
ATCCGTCCCTCCTAGTGGCGTGAGCTGA
TCCTGATGG-Azide-3’ 
IgE aptamer sequence flanked by 
primer binding sites (azide tag at 
3’ terminus) 
FP 5'-GGAAGAGATGGCGAC-3' Forward primer 
RP 5'-CCATCAGGATCAGCT-3' Reverse primer 
NCL-
Apt2 
5'-Cy5-
GGTGGTGGTGGTTGTGGTGGTGGTGGT
TTTTTTTTTTTTT-Azide-3' 
Nucleolin aptamer sequence with 
T14 sequence at 3’ terminus  
(Cy5 at 5’ terminus and azide tag 
at 3’ terminus) 
Th-
Apt2 
5'-Cy5-
GGGGCACGTTTATCCGTCCCTCCTAGTG
GCGTGCCCCTTTTTTTTTTTTT-Azide-
3' 
Thrombin aptamer sequence with 
T15 sequence at 3’ terminus  
(Cy5 at 5’ terminus and azide tag 
at 3’ terminus) 
IgE-
Apt2 
5'-Cy5-
GGGGCACGTTTATCCGTCCCTCCTAGTG
GCGTGCCCCTTTTTTTTTTTTT-Azide-
3' 
IgE aptamer sequence with T13 
sequence at 3’ terminus  
(Cy5 at 5’ terminus and azide tag 
at 3’ terminus) 
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Scheme S1: Synthetic mechanism of doxorubicin conjugation to the polymer 
scaffold via enzymatically-cleavable linkage 
 
 
 
 
 
 
 
 
 
 
 
Scheme S2: Synthetic mechanism of coumarin conjugation to the polymer scaffold 
via non-cleavable linkage 
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Figure S1: 5 µM polymer scaffold incubated with MCF-7 cells showed no big 
difference in cell viability compared to controls, which confirm that the polymer 
scaffold itself is not cytotoxic to the cells.  
 
 
 
 
Figure S2: Gel electrophoresis showed the successful conjugation via (BimC4A)3 
ligand-accelerated CuAAC to generate coumarin-loaded APH. Lanes: 1, 20-bp ladder; 
2, unconjugated aptamer; 3, unconjugated polymer that grafts coumarin dyes; 4, 
coumarin-loaded APH synthesized with (BimC4A)3. 
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Figure S3: Quantitative PCR (qPCR) amplification profiles verify aptamer integrity 
in our CuAAC scheme. The amplification curve of APHs synthesized with (BimC4A)3 
(red dotted line) overlaps with that of the unconjugated aptamer (black solid line), 
confirming that there is negligible damage resulting from conjugation. In contrast, 
APHs synthesized with (Bim)3 (green dashed line) exhibit a difference in threshold 
cycle (ΔCT) of ~1.11, indicating ~54% of the conjugated aptamers are damaged..  
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Figure S4: Gel electrophoresis confirmed that our CuAAC reaction with the 
(BimC4A)3 ligand is equally effective for the conjugation of intact aptamers for 
thrombin (left) or IgE (right). Lanes: 1, polymer only; 2, aptamer only; 3, (Bim)3-
conjugated APH; 4, (BimC4A)3-conjugated APH; 5, ladder. 
 
 
 
 
 
 
Figure S5: qPCR of thrombin (left) or IgE (right) APHs further confirms that CuAAC 
with (BimC4A)3 ligand offers a generalizable strategy for quantitative APH synthesis 
that leaves aptamers undamaged. 
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Figure S6: Affinity measurements for conjugated thrombin APH (top) versus an 
unconjugated mixture of thrombin aptamer and polymer (bottom) demonstrate that 
conjugation does not alter aptamer affinity, and that polymer binding is dependent 
on aptamer-mediated targeting. 
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Figure S7: Affinity measurements for conjugated IgE APH (top) versus an 
unconjugated mixture of IgE aptamer and polymer (bottom) demonstrate that 
conjugation does not alter aptamer affinity, and that polymer binding is dependent 
on aptamer-mediated targeting. 
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Figure S8: Measurement of coumarin payload release from the APH in 1x PBS (grey) 
or in undiluted human serum (blue). We observed no signal increase in human 
serum, indicating that the ester linkage between the payload and the APH should be 
stable under extracellular conditions, whereas it is selectively cleaved within an 
endosomal condition (red). 
 
 
 
 
 
 
Figure S9: Quantification of time-dependent payload release induced by PLE. (A) 
Linear relationship between different coumarin concentrations and fluorescent 
intensities in the presence of PLE (15 U/mL). (B) The amount of coumarin dyes 
released from 1 µM APH induced by PLE (15 U/mL) was calculated and plotted as a 
function of time. 
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Figure S10: PLE-dependent payload release from the APH. PLE is required for 
coumarin release, based on the concentration-dependent fluorescence increase 
observed over time in enzyme-treated APH samples (dashed lines) relative to the 
stable, low signal observed without enzyme (red).  
 
 
Figure S11: Measurement of coumarin release from the APH at different pH 
conditions. Unlike the fluorescence increase induced by PLE (red), no notable 
fluorescence increase of the APH was detected at a late endosomal pH, 5.4 (blue) 
and at a neutral pH, 7.4 (grey). 
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Figure S12: Live-cell imaging of APH-mediated, targeted coumarin delivery to MCF-
7 cells through confocal fluorescence microscopy. Scale bar= 40 µm. 
 
 
 
Figure S13: Optical microscopy images reveal efficient killing of MCF-7 cancer cells 
treated with (B) nucleolin-targeting, DOX-loaded APHs relative to cells treated with 
(C) unconjugated nucleolin-specific aptamers, (D) unconjugated DOX-loaded 
polymer scaffolds, and (E) culture media only. Scale bar = 100 µm. 
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Figure S14: Confirming the structure of poly(EGVGE)-b-(EO)(1). (A) We calculated 
the degree of polymerization for each repeat unit with 1H NMR spectroscopy. The 
singlet due to benzylic protons (inset) indicates EGVGE homopolymerization near 
the initiator5. (B) 13C NMR triad analysis (inset) indicates that triads of 
homopolymer units (EEE and VVV) are dominant with negligible amounts of 
alternating triads6. (C) Sharp melting/crystallization peaks and quantitative 
amounts of ∆H based on differential scanning calorimetry measurement imply the 
existence of a long homo-polyethylene oxide block. (D) Gel permeation 
chromatography (GPC) indicates that the block-copolymer has a narrow 
polydispersity.  
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Figure S15: All functionalizations in Scheme 1 were sequentially monitored by 1H 
NMR spectroscopy after (A) polymerization, (B) alkyne functionalization of the end 
group, (C) alcohol deprotection, and (D) coumarin grafting via ester bond. In 
spectrum (D), the solvents dichloromethane (DCM) and triethylamine (TEA) slightly 
changed the chemical shift, and the unassigned peaks at 3.25 and 5.65 are from 1,3-
dicyclohexylurea, a byproduct of dicyclohexylcarbodiimide coupling. 
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Figure S16: Dye functionalization of the polymer scaffold (4) was confirmed by 
combining reflective index (top) and UV-vis detection (bottom) in GPC. The identical 
elution volume of the polymer and coumarin indicates that the payloads were 
successfully grafted onto the polymer scaffold. The polydispersity index measured 
via RI detector was 1.09.  
 
 
 S25 
 
 
Figure S17: Functionalizations in Scheme S1 were monitored by 1H NMR 
spectroscopy for (A) the alcohol-deprotected polymer (3), (B) succinic anhydride 
conjugation (6), and (C) grafting of doxorubicin via an enzymatically cleavable 
linkage (7). The unassigned peaks at 3.15 and 6.68 are from residual succinic 
anhydride and 4-dimethylaminopyridine, respectively. 
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Figure S18: Functionalizations in Scheme S2 were monitored by 1H NMR 
spectroscopy for (A) the starting polymer, (B) partial epoxidation of allyl group, and 
(C) grafting of coumarin via non-cleavable linkages. The resulting polymer scaffold 
also has narrow polydispersity (PDI = 1.11) as measured by GPC. 
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